These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Nkx3.1 mutant mice recapitulate early stages of prostate carcinogenesis. Kim MJ; Bhatia-Gaur R; Banach-Petrosky WA; Desai N; Wang Y; Hayward SW; Cunha GR; Cardiff RD; Shen MM; Abate-Shen C Cancer Res; 2002 Jun; 62(11):2999-3004. PubMed ID: 12036903 [TBL] [Abstract][Full Text] [Related]
4. Emergence of androgen independence at early stages of prostate cancer progression in Nkx3.1; Pten mice. Gao H; Ouyang X; Banach-Petrosky WA; Shen MM; Abate-Shen C Cancer Res; 2006 Aug; 66(16):7929-33. PubMed ID: 16912166 [TBL] [Abstract][Full Text] [Related]
5. MYC overexpression induces prostatic intraepithelial neoplasia and loss of Nkx3.1 in mouse luminal epithelial cells. Iwata T; Schultz D; Hicks J; Hubbard GK; Mutton LN; Lotan TL; Bethel C; Lotz MT; Yegnasubramanian S; Nelson WG; Dang CV; Xu M; Anele U; Koh CM; Bieberich CJ; De Marzo AM PLoS One; 2010 Feb; 5(2):e9427. PubMed ID: 20195545 [TBL] [Abstract][Full Text] [Related]
6. Decreased NKX3.1 protein expression in focal prostatic atrophy, prostatic intraepithelial neoplasia, and adenocarcinoma: association with gleason score and chromosome 8p deletion. Bethel CR; Faith D; Li X; Guan B; Hicks JL; Lan F; Jenkins RB; Bieberich CJ; De Marzo AM Cancer Res; 2006 Nov; 66(22):10683-90. PubMed ID: 17108105 [TBL] [Abstract][Full Text] [Related]
7. Interaction of the Androgen Receptor, ETV1, and PTEN Pathways in Mouse Prostate Varies with Pathological Stage and Predicts Cancer Progression. Higgins J; Brogley M; Palanisamy N; Mehra R; Ittmann MM; Li JZ; Tomlins SA; Robins DM Horm Cancer; 2015 Jun; 6(2-3):67-86. PubMed ID: 25631336 [TBL] [Abstract][Full Text] [Related]
8. Initiation of prostate cancer in mice by Tp53R270H: evidence for an alternative molecular progression. Vinall RL; Chen JQ; Hubbard NE; Sulaimon SS; Shen MM; Devere White RW; Borowsky AD Dis Model Mech; 2012 Nov; 5(6):914-20. PubMed ID: 22563073 [TBL] [Abstract][Full Text] [Related]
9. Cooperativity of Nkx3.1 and Pten loss of function in a mouse model of prostate carcinogenesis. Kim MJ; Cardiff RD; Desai N; Banach-Petrosky WA; Parsons R; Shen MM; Abate-Shen C Proc Natl Acad Sci U S A; 2002 Mar; 99(5):2884-9. PubMed ID: 11854455 [TBL] [Abstract][Full Text] [Related]
10. Co-clinical Analysis of a Genetically Engineered Mouse Model and Human Prostate Cancer Reveals Significance of NKX3.1 Expression for Response to 5α-reductase Inhibition. Dutta A; Panja S; Virk RK; Kim JY; Zott R; Cremers S; Golombos DM; Liu D; Mosquera JM; Mostaghel EA; Barbieri CE; Mitrofanova A; Abate-Shen C Eur Urol; 2017 Oct; 72(4):499-506. PubMed ID: 28385453 [TBL] [Abstract][Full Text] [Related]
11. Id4 deficiency attenuates prostate development and promotes PIN-like lesions by regulating androgen receptor activity and expression of NKX3.1 and PTEN. Sharma P; Knowell AE; Chinaranagari S; Komaragiri S; Nagappan P; Patel D; Havrda MC; Chaudhary J Mol Cancer; 2013 Jun; 12():67. PubMed ID: 23786676 [TBL] [Abstract][Full Text] [Related]
12. Loss of Nkx3.1 leads to the activation of discrete downstream target genes during prostate tumorigenesis. Song H; Zhang B; Watson MA; Humphrey PA; Lim H; Milbrandt J Oncogene; 2009 Sep; 28(37):3307-19. PubMed ID: 19597465 [TBL] [Abstract][Full Text] [Related]
13. Loss-of-function of Nkx3.1 promotes increased oxidative damage in prostate carcinogenesis. Ouyang X; DeWeese TL; Nelson WG; Abate-Shen C Cancer Res; 2005 Aug; 65(15):6773-9. PubMed ID: 16061659 [TBL] [Abstract][Full Text] [Related]
14. The pace of prostatic intraepithelial neoplasia development is determined by the timing of Pten tumor suppressor gene excision. Luchman HA; Benediktsson H; Villemaire ML; Peterson AC; Jirik FR PLoS One; 2008; 3(12):e3940. PubMed ID: 19081794 [TBL] [Abstract][Full Text] [Related]
15. Regression of mouse prostatic intraepithelial neoplasia by nonsteroidal anti-inflammatory drugs in the transgenic adenocarcinoma mouse prostate model. Narayanan BA; Narayanan NK; Pittman B; Reddy BS Clin Cancer Res; 2004 Nov; 10(22):7727-37. PubMed ID: 15570007 [TBL] [Abstract][Full Text] [Related]
16. Prolonged exposure to reduced levels of androgen accelerates prostate cancer progression in Nkx3.1; Pten mutant mice. Banach-Petrosky W; Jessen WJ; Ouyang X; Gao H; Rao J; Quinn J; Aronow BJ; Abate-Shen C Cancer Res; 2007 Oct; 67(19):9089-96. PubMed ID: 17909013 [TBL] [Abstract][Full Text] [Related]
17. Plumbagin Inhibits Prostate Carcinogenesis in Intact and Castrated PTEN Knockout Mice via Targeting PKCε, Stat3, and Epithelial-to-Mesenchymal Transition Markers. Hafeez BB; Fischer JW; Singh A; Zhong W; Mustafa A; Meske L; Sheikhani MO; Verma AK Cancer Prev Res (Phila); 2015 May; 8(5):375-86. PubMed ID: 25627799 [TBL] [Abstract][Full Text] [Related]
18. Cooperation between FGF8b overexpression and PTEN deficiency in prostate tumorigenesis. Zhong C; Saribekyan G; Liao CP; Cohen MB; Roy-Burman P Cancer Res; 2006 Feb; 66(4):2188-94. PubMed ID: 16489020 [TBL] [Abstract][Full Text] [Related]
19. Loss of glutathione peroxidase 3 induces ROS and contributes to prostatic hyperplasia in Nkx3.1 knockout mice. Kim U; Kim CY; Lee JM; Ryu B; Kim J; Bang J; Ahn N; Park JH Andrology; 2020 Sep; 8(5):1486-1493. PubMed ID: 32450005 [TBL] [Abstract][Full Text] [Related]
20. Molecular evidence that invasive adenocarcinoma can mimic prostatic intraepithelial neoplasia (PIN) and intraductal carcinoma through retrograde glandular colonization. Haffner MC; Weier C; Xu MM; Vaghasia A; Gürel B; Gümüşkaya B; Esopi DM; Fedor H; Tan HL; Kulac I; Hicks J; Isaacs WB; Lotan TL; Nelson WG; Yegnasubramanian S; De Marzo AM J Pathol; 2016 Jan; 238(1):31-41. PubMed ID: 26331372 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]